CEO & Chairman
RedHill Biopharma
(NASDAQ: RDHL)
Dror Ben-Asher co-founded RedHill and serves as the Company’s CEO and Chairman, bringing extensive managerial and transactional expertise. He was previously with ProSeed Capital, a European corporate finance boutique. Dror is a graduate of the University of Oxford (M.Jur.) and completed his LL.M. studies at Harvard University. At Harvard, Dror was also a Fulbright Scholar focusing on the pharmaceutical industry and markets, an Olin Fellow for Law, Economics and Business, and an Economics Teaching Fellow at Harvard’s Economics Department.
Dror received an LL.B. with distinction (First Class Honors) from the University of Leicester.